Spray Products
IGNITE
PT-141 + Oxy (oxytocin)
35mg / bottle
SKU: BM-SPR-008
Limited initial run. Estimated dispatch: early November 2026. Timing may change.
Charged at checkout. Preorders check out separately from in-stock items.
$129.00$109.65
$109.65 / bottle
Available for preorder
A spray formula combining PT-141 and Oxy (oxytocin), with a listed total content of 35 mg per bottle.
Pack size
Not for human or animal use. Available to customers age 21 and older.
Available shipping services and charges are shown at checkout before payment.
Product & batch record
PT-141 + Oxy (oxytocin) · Spray
- Lot
- SPR-008-2608-01
The lab report for this lot is being updated. Ask us anytime for the latest documentation.
Match this lot to the label on your vial.
Product specifications
- Product
- IGNITE
- Compound / identity
- PT-141 + Oxy (oxytocin)
- Format
- Spray
- Size
- 35mg / bottle
- SKU
- BM-SPR-008
- CAS
- 189691-06-3 / 50-56-6
- Use
- Laboratory research only
A spray formula combining PT-141 and Oxy (oxytocin), with a listed total content of 35 mg per bottle.
IGNITE 35mg from Biomod Research Supply Company is supplied as a single spray bottle with listed contents of 35mg per bottle (SKU BM-SPR-008, CAS 189691-06-3 / 50-56-6). The listed identity is PT-141 + Oxy (oxytocin).
The lab report for lot SPR-008-2608-01 is being updated. Contact BIOMOD anytime for the latest documentation.
Order a single bottle or a 3, 5 or 10-pack; each pack price on this page is shown per bottle.
Supplied for laboratory, analytical, and scientific research. Review the listed identity, container contents, and batch record before purchase.
Explore the catalog
Spray Products
APEX
Semax
60 mg / bottle
Limited initial run. Estimated dispatch: early November 2026. Timing may change.
Spray Products
EQUIL
Selank
60 mg / bottle
Limited initial run. Estimated dispatch: early November 2026. Timing may change.
Spray Products
FLUX
NAD+ (Nicotinamide Adenine Dinucleotide)
1000 mg / bottle
Limited initial run. Estimated dispatch: early November 2026. Timing may change.